ANK1 inhibits malignant progression of osteosarcoma by promoting ferroptosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

ANK1 inhibits malignant progression of osteosarcoma by promoting ferroptosis

Published:2024-08-31 Issue:1 Volume:24 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Zhang Fei,Wan Junming,Zhong Jinghua,Mo Jianwen

Funder

Science and Technology Research Project of Jiangxi Provincial Department of Education

Research Project of Gannan Medical University

Natural Science Foundation of Zhejiang Province

Natural Science Foundation of Zhejiang Province Joint Fund Project

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1186/s12885-024-12836-z.pdf

Reference38 articles.

1. Chen C, et al. Immunotherapy for osteosarcoma: fundamental mechanism, rationale, and recent breakthroughs. Cancer Lett. 2021;500:1–10.

2. Ritter J, S. Bielack S. Osteosarcoma. Ann Oncol. 2010;21(Suppl 7):vii320–5.

3. Corre I et al. The Osteosarcoma Microenvironment: a Complex but Targetable Ecosystem. Cells. 2020. 9(4).

4. Wittig JC, et al. Osteosarcoma: a multidisciplinary approach to diagnosis and treatment. Am Fam Physician. 2002;65(6):1123–32.

5. Bennett V, Chen L. Ankyrins and cellular targeting of diverse membrane proteins to physiological sites. Curr Opin Cell Biol. 2001;13(1):61–7.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP